主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | James E. Davis | 否 | 11.40万 | 0.98% | 新增 | 新增 | 0.9820% |
| 2 | Catherine T. Doherty | 否 | 6.49万 | 0.56% | 新增 | 新增 | 0.5586% |
| 3 | Michael E. Prevoznik | 否 | 3.86万 | 0.33% | 新增 | 新增 | 0.3328% |
| 4 | Timothy L. Main | 否 | 2.23万 | 0.19% | 新增 | 新增 | 0.1918% |
| 5 | Sam A. Samad | 否 | 1.51万 | 0.13% | 新增 | 新增 | 0.1299% |
| 6 | Vicky B. Gregg | 否 | 1.40万 | 0.12% | 新增 | 新增 | 0.1209% |
| 7 | Karthik Kuppusamy | 否 | 1.01万 | 0.09% | 新增 | 新增 | 0.0869% |
| 8 | Denise M. Morrison | 否 | 0.42万 | 0.04% | 新增 | 新增 | 0.0363% |
| 9 | Luiz A. Diaz, Jr. | 否 | 0.05万 | 0.0039% | 新增 | 新增 | 0.0039% |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-11-25 | Gregg Vicky B |
|
1.70 | 191.76 | 是 | -- |
| 2025-11-25 | Davis J. E. |
|
17.56 | 95.80 | 是 | CEO and President |
| 2025-11-25 | Davis J. E. |
|
16.62 | 191.59 | 是 | CEO and President |
| 2025-11-25 | Davis J. E. |
|
12.52 | 192.27 | 是 | CEO and President |
| 2025-11-25 | Davis J. E. |
|
12.05 | 192.97 | 是 | CEO and President |
| 2025-11-18 | DELANEY MARK E |
|
1.54 | 144.47 | 是 | SVP & Chief Commercial Officer |
| 2025-11-18 | DELANEY MARK E |
|
1.55 | 143.33 | 是 | SVP & Chief Commercial Officer |
| 2025-11-18 | DELANEY MARK E |
|
0.75 | 187.35 | 是 | SVP & Chief Commercial Officer |
| 2025-11-05 | Davis J. E. |
|
12.05 | 175.57 | 是 | CEO and President |
| 2025-10-22 | PFEIFFER GARY M |
|
2.94 | 182.40 | 是 | -- |
| 2025-09-26 | PREVOZNIK MICHAEL E |
|
3.83 | 103.57 | 是 | SVP & General Counsel |
| 2025-09-26 | PREVOZNIK MICHAEL E |
|
3.81 | 188.66 | 是 | SVP & General Counsel |
| 2025-09-23 | PREVOZNIK MICHAEL E |
|
6.64 | 103.57 | 是 | SVP & General Counsel |
| 2025-09-23 | PREVOZNIK MICHAEL E |
|
3.81 | 187.12 | 是 | SVP & General Counsel |
| 2025-09-23 | PREVOZNIK MICHAEL E |
|
3.83 | 103.57 | 是 | SVP & General Counsel |
| 2025-09-23 | PREVOZNIK MICHAEL E |
|
3.81 | 187.02 | 是 | SVP & General Counsel |
| 2025-08-21 | Plewman Patrick |
|
1.53 | 185.00 | 是 | SVP for Diagnostic Services |
| 2025-08-19 | Plewman Patrick |
|
2.18 | 112.17 | 是 | SVP for Diagnostic Services |
| 2025-08-19 | Plewman Patrick |
|
1.72 | 183.00 | 是 | SVP for Diagnostic Services |
| 2025-08-15 | Plewman Patrick |
|
1.72 | 180.00 | 是 | SVP for Diagnostic Services |
| 2025-08-13 | KUPPUSAMY KARTHIK |
|
0.83 | 175.91 | 是 | SVP, Clinical Solutions |
| 2025-08-06 | Plewman Patrick |
|
2.47 | 86.63 | 是 | SVP for Diagnostic Services |
| 2025-08-06 | Plewman Patrick |
|
2.12 | 175.00 | 是 | SVP for Diagnostic Services |
| 2025-08-06 | Plewman Patrick |
|
1.92 | 175.00 | 是 | SVP for Diagnostic Services |
| 2025-07-30 | KUPPUSAMY KARTHIK |
|
1.07 | 167.40 | 是 | SVP, Clinical Solutions |
| 2025-07-30 | KUPPUSAMY KARTHIK |
|
0.85 | 170.00 | 是 | SVP, Clinical Solutions |
| 2025-07-30 | KUPPUSAMY KARTHIK |
|
1.37 | 86.63 | 是 | SVP, Clinical Solutions |
| 2025-07-30 | KUPPUSAMY KARTHIK |
|
1.07 | 167.40 | 是 | SVP, Clinical Solutions |
| 2025-07-30 | KUPPUSAMY KARTHIK |
|
1.59 | 112.17 | 是 | SVP, Clinical Solutions |
| 2025-07-16 | SAMAD SAM |
|
2.56 | 169.01 | 是 | Executive Vice President & CFO |
| 2025-05-15 | PFEIFFER GARY M |
|
3.07 | 0.00 | 是 | -- |
| 2025-05-15 | RING TIMOTHY M |
|
2.95 | 0.00 | 是 | -- |
| 2025-05-15 | MORRISON DENISE M |
|
1.07 | 0.00 | 是 | -- |
| 2025-05-15 | Lassiter Wright III |
|
0.90 | 0.00 | 是 | -- |
| 2025-05-15 | MAIN TIMOTHY L |
|
2.63 | 0.00 | 是 | -- |
| 2025-05-15 | CARTER ROBERT B |
|
0.27 | 0.00 | 是 | -- |
| 2025-05-15 | Gregg Vicky B |
|
1.81 | 0.00 | 是 | -- |
| 2025-05-15 | Doi Tracey |
|
0.65 | 0.00 | 是 | -- |
| 2025-05-15 | Diaz Luis |
|
0.41 | 0.00 | 是 | -- |
| 2025-05-12 | DELANEY MARK E |
|
0.84 | 175.72 | 是 | SVP & Chief Commercial Officer |
| 2025-05-12 | DELANEY MARK E |
|
0.75 | 175.31 | 是 | SVP & Chief Commercial Officer |
| 2025-04-02 | KUPPUSAMY KARTHIK |
|
1.06 | 170.00 | 是 | SVP, Clinical Solutions |
| 2025-04-02 | Davis J. E. |
|
16.44 | 168.03 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
16.30 | 168.76 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
16.23 | 169.63 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
15.51 | 167.86 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
15.02 | 168.72 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
14.74 | 169.56 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
14.05 | 167.86 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
13.46 | 168.66 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
13.21 | 169.57 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
13.13 | 167.86 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
13.07 | 168.70 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
13.05 | 169.60 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
12.90 | 167.88 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
12.81 | 168.79 | 是 | CEO and President |
| 2025-04-02 | Davis J. E. |
|
12.76 | 169.63 | 是 | CEO and President |
| 2025-03-26 | Plewman Patrick |
|
2.10 | 166.71 | 是 | SVP for Diagnostic Services |
| 2025-03-26 | DELANEY MARK E |
|
0.92 | 166.71 | 是 | SVP & Chief Commercial Officer |
| 2025-03-17 | PREVOZNIK MICHAEL E |
|
3.81 | 170.00 | 是 | SVP & General Counsel |
| 2025-03-05 | Doherty Catherine T. |
|
6.81 | 174.13 | 是 | EVP, Regional Businesses |
| 2025-03-04 | DELANEY MARK E |
|
1.13 | 173.74 | 是 | SVP & Chief Commercial Officer |
| 2025-03-04 | DELANEY MARK E |
|
0.95 | 173.74 | 是 | SVP & Chief Commercial Officer |
| 2025-03-04 | SAMAD SAM |
|
3.41 | 173.74 | 是 | Executive Vice President & CFO |
| 2025-03-04 | SAMAD SAM |
|
2.64 | 173.74 | 是 | Executive Vice President & CFO |
| 2025-03-03 | Davis J. E. |
|
13.66 | 173.74 | 是 | CEO and President |
| 2025-03-03 | Davis J. E. |
|
19.85 | 173.74 | 是 | CEO and President |
| 2025-03-03 | Davis J. E. |
|
16.68 | 173.74 | 是 | CEO and President |
| 2025-03-03 | Doherty Catherine T. |
|
6.88 | 173.74 | 是 | EVP, Regional Businesses |
| 2025-03-03 | Doherty Catherine T. |
|
6.81 | 175.79 | 是 | EVP, Regional Businesses |
| 2025-03-03 | Doherty Catherine T. |
|
7.84 | 173.74 | 是 | EVP, Regional Businesses |
| 2025-03-03 | Doherty Catherine T. |
|
7.34 | 173.74 | 是 | EVP, Regional Businesses |
| 2025-03-03 | DEPPE MICHAEL J |
|
3.35 | 173.74 | 是 | SVP, Corp. Controller & CAO |
| 2025-03-03 | DEPPE MICHAEL J |
|
3.52 | 173.74 | 是 | SVP, Corp. Controller & CAO |
| 2025-03-03 | DEPPE MICHAEL J |
|
3.44 | 173.74 | 是 | SVP, Corp. Controller & CAO |
| 2025-03-03 | PREVOZNIK MICHAEL E |
|
3.87 | 173.74 | 是 | SVP & General Counsel |
| 2025-03-03 | PREVOZNIK MICHAEL E |
|
3.81 | 175.79 | 是 | SVP & General Counsel |
| 2025-03-03 | PREVOZNIK MICHAEL E |
|
4.67 | 173.74 | 是 | SVP & General Counsel |
| 2025-03-03 | PREVOZNIK MICHAEL E |
|
4.28 | 173.74 | 是 | SVP & General Counsel |
| 2025-03-03 | Plewman Patrick |
|
1.78 | 173.74 | 是 | SVP for Diagnostic Services |
| 2025-03-03 | Plewman Patrick |
|
2.34 | 173.74 | 是 | SVP for Diagnostic Services |
| 2025-03-03 | Plewman Patrick |
|
2.12 | 173.74 | 是 | SVP for Diagnostic Services |
| 2025-03-03 | KUPPUSAMY KARTHIK |
|
1.06 | 173.74 | 是 | SVP, Clinical Solutions |
| 2025-03-03 | KUPPUSAMY KARTHIK |
|
1.50 | 173.74 | 是 | SVP, Clinical Solutions |
| 2025-03-03 | KUPPUSAMY KARTHIK |
|
1.31 | 173.74 | 是 | SVP, Clinical Solutions |
| 2025-02-26 | SAMAD SAM |
|
2.02 | 171.75 | 是 | Executive Vice President & CFO |
| 2025-02-26 | Davis J. E. |
|
13.82 | 171.75 | 是 | CEO and President |
| 2025-02-26 | PREVOZNIK MICHAEL E |
|
3.96 | 171.75 | 是 | SVP & General Counsel |
| 2025-02-26 | PREVOZNIK MICHAEL E |
|
3.90 | 172.61 | 是 | SVP & General Counsel |
| 2025-02-26 | Plewman Patrick |
|
1.79 | 171.75 | 是 | SVP for Diagnostic Services |
| 2025-02-26 | KUPPUSAMY KARTHIK |
|
1.15 | 171.75 | 是 | SVP, Clinical Solutions |
| 2025-02-26 | Doherty Catherine T. |
|
6.92 | 172.61 | 是 | EVP, Regional Businesses |
| 2025-02-26 | Doherty Catherine T. |
|
7.00 | 171.75 | 是 | EVP, Regional Businesses |
| 2025-02-26 | DELANEY MARK E |
|
0.60 | 171.75 | 是 | SVP & Chief Commercial Officer |
| 2025-02-19 | Plewman Patrick |
|
1.81 | 169.71 | 是 | SVP for Diagnostic Services |
| 2025-02-19 | KUPPUSAMY KARTHIK |
|
1.18 | 169.71 | 是 | SVP, Clinical Solutions |
| 2025-02-19 | Doherty Catherine T. |
|
7.14 | 169.71 | 是 | EVP, Regional Businesses |
| 2025-02-19 | Doherty Catherine T. |
|
7.05 | 170.99 | 是 | EVP, Regional Businesses |
| 2025-02-19 | DELANEY MARK E |
|
0.62 | 169.71 | 是 | SVP & Chief Commercial Officer |
| 2025-02-19 | Davis J. E. |
|
14.12 | 169.71 | 是 | CEO and President |
| 2025-02-19 | SAMAD SAM |
|
2.10 | 169.71 | 是 | Executive Vice President & CFO |
| 2025-02-19 | PREVOZNIK MICHAEL E |
|
4.04 | 169.71 | 是 | SVP & General Counsel |
| 2025-02-19 | PREVOZNIK MICHAEL E |
|
3.98 | 170.99 | 是 | SVP & General Counsel |
| 2025-02-12 | Davis J. E. |
|
14.41 | 0.00 | 是 | CEO and President |
| 2025-02-12 | SAMAD SAM |
|
2.21 | 0.00 | 是 | Executive Vice President & CFO |
| 2025-02-12 | PREVOZNIK MICHAEL E |
|
4.08 | 0.00 | 是 | SVP & General Counsel |
| 2025-02-12 | Plewman Patrick |
|
1.84 | 0.00 | 是 | SVP for Diagnostic Services |
| 2025-02-12 | Doherty Catherine T. |
|
7.19 | 0.00 | 是 | EVP, Regional Businesses |
| 2025-02-12 | KUPPUSAMY KARTHIK |
|
1.21 | 0.00 | 是 | SVP, Clinical Solutions |
| 2025-02-12 | DELANEY MARK E |
|
0.64 | 0.00 | 是 | SVP & Chief Commercial Officer |
| 2025-02-12 | DEPPE MICHAEL J |
|
3.54 | 0.00 | 是 | SVP, Corp. Controller & CAO |
| 2025-02-05 | DELANEY MARK E |
|
0.46 | 164.30 | 是 | SVP & Chief Commercial Officer |
| 2025-02-05 | Gregg Vicky B |
|
1.69 | 164.57 | 是 | -- |
| 2024-11-29 | PREVOZNIK MICHAEL E |
|
7.36 | 86.63 | 是 | SVP & General Counsel |
| 2024-11-29 | PREVOZNIK MICHAEL E |
|
7.06 | 162.26 | 是 | SVP & General Counsel |
| 2024-11-29 | PREVOZNIK MICHAEL E |
|
3.85 | 163.15 | 是 | SVP & General Counsel |
| 2024-11-27 | Doherty Catherine T. |
|
10.15 | 103.57 | 是 | EVP, Regional Businesses |
| 2024-11-27 | Doherty Catherine T. |
|
9.67 | 162.14 | 是 | EVP, Regional Businesses |
| 2024-11-27 | Doherty Catherine T. |
|
6.84 | 163.13 | 是 | EVP, Regional Businesses |
| 2024-11-06 | DEPPE MICHAEL J |
|
4.36 | 71.17 | 是 | SVP, Corp. Controller & CAO |
| 2024-11-06 | DEPPE MICHAEL J |
|
5.37 | 66.51 | 是 | SVP, Corp. Controller & CAO |
| 2024-11-06 | DEPPE MICHAEL J |
|
5.16 | 152.70 | 是 | SVP, Corp. Controller & CAO |
| 2024-11-06 | DEPPE MICHAEL J |
|
4.92 | 153.98 | 是 | SVP, Corp. Controller & CAO |
| 2024-11-06 | DEPPE MICHAEL J |
|
4.51 | 154.74 | 是 | SVP, Corp. Controller & CAO |
| 2024-11-06 | DEPPE MICHAEL J |
|
4.25 | 152.71 | 是 | SVP, Corp. Controller & CAO |
| 2024-11-06 | DEPPE MICHAEL J |
|
4.01 | 154.03 | 是 | SVP, Corp. Controller & CAO |
| 2024-11-06 | DEPPE MICHAEL J |
|
3.49 | 154.74 | 是 | SVP, Corp. Controller & CAO |
| 2024-10-28 | KUPPUSAMY KARTHIK |
|
0.97 | 156.92 | 是 | SVP, Clinical Solutions |
| 2024-09-24 | GARDNER MARK A |
|
0.47 | 155.70 | 是 | SVP of Molecular Gen & Oncol |
| 2024-08-29 | PREVOZNIK MICHAEL E |
|
7.10 | 95.80 | 是 | SVP & General Counsel |
| 2024-08-29 | PREVOZNIK MICHAEL E |
|
3.85 | 154.97 | 是 | SVP & General Counsel |
| 2024-08-28 | KUPPUSAMY KARTHIK |
|
1.15 | 153.26 | 是 | SVP, Clinical Solutions |
| 2024-07-24 | DELANEY MARK E |
|
0.50 | 143.08 | 是 | SVP & Chief Commercial Officer |
| 2024-07-16 | SAMAD SAM |
|
1.74 | 142.65 | 是 | Executive Vice President & CFO |
| 2024-05-16 | CARTER ROBERT B |
|
0.15 | 0.00 | 是 | -- |
| 2024-05-16 | Diaz Luis |
|
0.29 | 0.00 | 是 | -- |
| 2024-05-16 | MORRISON DENISE M |
|
0.95 | 0.00 | 是 | -- |
| 2024-05-16 | Doi Tracey |
|
0.52 | 0.00 | 是 | -- |
| 2024-05-16 | Lassiter Wright III |
|
0.77 | 0.00 | 是 | -- |
| 2024-05-16 | Gregg Vicky B |
|
1.79 | 0.00 | 是 | -- |
| 2024-05-16 | MAIN TIMOTHY L |
|
2.51 | 0.00 | 是 | -- |
| 2024-05-16 | RING TIMOTHY M |
|
2.78 | 0.00 | 是 | -- |
| 2024-05-16 | PFEIFFER GARY M |
|
2.89 | 0.00 | 是 | -- |
| 2024-04-29 | KUPPUSAMY KARTHIK |
|
1.34 | 140.00 | 是 | SVP, Clinical Solutions |
| 2024-03-26 | DELANEY MARK E |
|
0.54 | 128.11 | 是 | SVP & Chief Commercial Officer |
| 2024-03-26 | Plewman Patrick |
|
1.60 | 128.11 | 是 | SVP for Diagnostic Services |
| 2024-02-28 | DELANEY MARK E |
|
0.56 | 126.36 | 是 | SVP & Chief Commercial Officer |
| 2024-02-28 | Doherty Catherine T. |
|
7.57 | 126.36 | 是 | EVP, Regional Businesses |
| 2024-02-28 | Doherty Catherine T. |
|
7.52 | 126.36 | 是 | EVP, Regional Businesses |
| 2024-02-28 | Doherty Catherine T. |
|
6.96 | 126.57 | 是 | EVP, Regional Businesses |
| 2024-02-28 | Doherty Catherine T. |
|
6.84 | 125.88 | 是 | EVP, Regional Businesses |
| 2024-02-28 | PREVOZNIK MICHAEL E |
|
4.41 | 126.36 | 是 | SVP & General Counsel |
| 2024-02-28 | PREVOZNIK MICHAEL E |
|
3.85 | 125.88 | 是 | SVP & General Counsel |
| 2024-02-28 | PREVOZNIK MICHAEL E |
|
4.45 | 126.36 | 是 | SVP & General Counsel |
| 2024-02-28 | KUPPUSAMY KARTHIK |
|
1.52 | 126.36 | 是 | SVP, Clinical Solutions |
| 2024-02-28 | SAMAD SAM |
|
2.13 | 126.36 | 是 | Executive Vice President & CFO |
| 2024-02-28 | Davis J. E. |
|
12.78 | 126.36 | 是 | CEO and President |
| 2024-02-28 | Davis J. E. |
|
12.60 | 126.36 | 是 | CEO and President |
| 2024-02-28 | GARDNER MARK A |
|
0.48 | 126.36 | 是 | SVP of Molecular Gen & Oncol |
| 2024-02-28 | Plewman Patrick |
|
1.62 | 126.36 | 是 | SVP for Diagnostic Services |
| 2024-02-28 | Plewman Patrick |
|
1.61 | 126.36 | 是 | SVP for Diagnostic Services |
| 2024-02-23 | Gregg Vicky B |
|
1.63 | 126.64 | 是 | -- |
| 2024-02-23 | PREVOZNIK MICHAEL E |
|
4.78 | 125.02 | 是 | SVP & General Counsel |
| 2024-02-23 | PREVOZNIK MICHAEL E |
|
4.50 | 125.02 | 是 | SVP & General Counsel |
| 2024-02-23 | Plewman Patrick |
|
1.64 | 125.02 | 是 | SVP for Diagnostic Services |
| 2024-02-23 | Doherty Catherine T. |
|
8.01 | 125.02 | 是 | EVP, Regional Businesses |
| 2024-02-23 | Doherty Catherine T. |
|
7.64 | 125.02 | 是 | EVP, Regional Businesses |
| 2024-02-23 | Plewman Patrick |
|
1.73 | 125.02 | 是 | SVP for Diagnostic Services |
| 2024-02-23 | Davis J. E. |
|
13.75 | 125.02 | 是 | CEO and President |
| 2024-02-23 | Davis J. E. |
|
13.10 | 125.02 | 是 | CEO and President |
| 2024-02-23 | KUPPUSAMY KARTHIK |
|
1.60 | 125.02 | 是 | SVP, Clinical Solutions |
| 2024-02-23 | KUPPUSAMY KARTHIK |
|
1.54 | 125.02 | 是 | SVP, Clinical Solutions |
| 2024-02-23 | DEPPE MICHAEL J |
|
3.50 | 125.02 | 是 | SVP, Corp. Controller & CAO |
| 2024-02-23 | DEPPE MICHAEL J |
|
3.57 | 125.02 | 是 | SVP, Corp. Controller & CAO |
| 2024-02-21 | PREVOZNIK MICHAEL E |
|
4.09 | 125.02 | 是 | SVP & General Counsel |
| 2024-02-21 | PREVOZNIK MICHAEL E |
|
4.02 | 126.14 | 是 | SVP & General Counsel |
| 2024-02-21 | Plewman Patrick |
|
1.49 | 125.02 | 是 | SVP for Diagnostic Services |
| 2024-02-21 | Davis J. E. |
|
12.41 | 125.02 | 是 | CEO and President |
| 2024-02-21 | Doherty Catherine T. |
|
7.08 | 126.14 | 是 | EVP, Regional Businesses |
| 2024-02-21 | Doherty Catherine T. |
|
7.16 | 125.02 | 是 | EVP, Regional Businesses |
| 2024-02-21 | KUPPUSAMY KARTHIK |
|
1.40 | 125.02 | 是 | SVP, Clinical Solutions |
| 2024-02-14 | Doherty Catherine T. |
|
7.21 | 0.00 | 是 | SVP, Regional Businesses |
| 2024-02-14 | DEPPE MICHAEL J |
|
3.41 | 0.00 | 是 | SVP, Corp. Controller & CAO |
| 2024-02-14 | KUPPUSAMY KARTHIK |
|
1.41 | 0.00 | 是 | SVP, Clinical Solutions |
| 2024-02-14 | PREVOZNIK MICHAEL E |
|
4.13 | 0.00 | 是 | SVP & General Counsel |
| 2024-02-14 | SAMAD SAM |
|
2.20 | 0.00 | 是 | Executive Vice President & CFO |
| 2024-02-14 | DELANEY MARK E |
|
0.58 | 0.00 | 是 | SVP & Chief Commercial Officer |
| 2024-02-14 | GARDNER MARK A |
|
0.51 | 0.00 | 是 | SVP of Molecular Gen & Oncol |
| 2024-02-14 | Plewman Patrick |
|
1.50 | 0.00 | 是 | SVP for Diagnostic Services |
| 2024-02-14 | Davis J. E. |
|
12.49 | 0.00 | 是 | CEO and President |
| 2023-12-31 | PREVOZNIK MICHAEL E |
|
3.83 | 0.00 | 是 | SVP & General Counsel |